FDA Approved: OLANZAPINE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for OLANZAPINE from Jubilant Cadista Pharmaceuticals Inc. This is a routine regulatory action updating the approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)